FDA Approves First Treatment for Niemann-Pick Disease, Type C

Estimated reading time: 1 minutes

• About The Author

The FDA approved Miplyffa (arimoclomol), an oral medication for the treatment of Neimann-Pick disease, type C (NPC). Miplyffa is the first drug approved by the FDA to treat NPC.

About The Author

See author's posts

Trending

Android malware steals payment card data using previously unseen technique